| 12/06/26 | 07:00:06 | 12 Jun 2026 | | Momelotinib orphan drug designations for VEXAS |
| 11/06/26 | 15:30:01 | 11 Jun 2026 | | Director/PDMR Shareholding |
| 10/06/26 | 15:30:00 | 10 Jun 2026 | | Director/PDMR Shareholding |
| 09/06/26 | 17:51:15 | 9 Jun 2026 | | Dr Hal Barron – New Directorship |
| 09/06/26 | 07:00:01 | 9 Jun 2026 | | GSK enters agreement to acquire Nuvalent, Inc. |
| 08/06/26 | 15:00:00 | 8 Jun 2026 | | Transaction in Own Shares |
| 01/06/26 | 15:00:00 | 1 Jun 2026 | | Total Voting Rights |
| 01/06/26 | 15:00:00 | 1 Jun 2026 | | Transaction in Own Shares |
| 28/05/26 | 09:30:00 | 28 May 2026 | | Positive Phase 3 data for bepirovirsen |
| 27/05/26 | 15:30:00 | 27 May 2026 | | Director/PDMR Shareholding |
| 26/05/26 | 15:00:00 | 26 May 2026 | | Admission to Trading |
| 26/05/26 | 15:00:00 | 26 May 2026 | | Transaction in Own Shares |
| 22/05/26 | 10:30:28 | 22 May 2026 | | Q2 2026 Results Date Confirmed - 28 July 2026 |
| 20/05/26 | 15:30:01 | 20 May 2026 | | Director/PDMR Shareholding |
| 19/05/26 | 15:30:01 | 19 May 2026 | | Director/PDMR Shareholding |
| 18/05/26 | 15:00:00 | 18 May 2026 | | Transaction in Own Shares |
| 18/05/26 | 07:00:09 | 18 May 2026 | | Japan MHLW approves Arexvy for adults 18-49 AIR |
| 14/05/26 | 15:30:00 | 14 May 2026 | | Director/PDMR Shareholding |
| 11/05/26 | 15:30:00 | 11 May 2026 | | Director/PDMR Shareholding |
| 11/05/26 | 07:05:00 | 11 May 2026 | | Collaboration with CTTQ for bepirovirsen |
| 11/05/26 | 07:00:10 | 11 May 2026 | | GSK - final tranche of share buyback programme |
| 06/05/26 | 18:22:16 | 6 May 2026 | | Result of AGM |
| 05/05/26 | 15:30:00 | 5 May 2026 | | Director/PDMR Shareholding |
| 01/05/26 | 15:00:01 | 1 May 2026 | | Holding(s) in Company |
| 01/05/26 | 15:00:00 | 1 May 2026 | | Total Voting Rights |
| 29/04/26 | 15:30:00 | 29 Apr 2026 | | Director/PDMR Shareholding |
| 29/04/26 | 07:00:03 | 29 Apr 2026 | | 1st Quarter Results |
| 28/04/26 | 15:30:00 | 28 Apr 2026 | | Director/PDMR Shareholding |
| 28/04/26 | 07:00:11 | 28 Apr 2026 | | Bepirovirsen priority review US filing acceptance |
| 27/04/26 | 12:00:02 | 27 Apr 2026 | | Efimosfermin granted US/EU regulatory designations |
| 27/04/26 | 07:00:09 | 27 Apr 2026 | | TESARO update on AnaptysBio Inc. litigation |
| 24/04/26 | 15:30:00 | 24 Apr 2026 | | Director/PDMR Shareholding |
| 23/04/26 | 07:00:04 | 23 Apr 2026 | | Transaction in Own Shares |
| 22/04/26 | 07:00:02 | 22 Apr 2026 | | Transaction in Own Shares |
| 21/04/26 | 07:00:03 | 21 Apr 2026 | | Transaction in Own Shares |
| 20/04/26 | 15:30:01 | 20 Apr 2026 | | Director/PDMR Shareholding |
| 20/04/26 | 07:00:05 | 20 Apr 2026 | | Blenrep approved in China for 2L+ multiple myeloma |
| 20/04/26 | 07:00:04 | 20 Apr 2026 | | Transaction in Own Shares |
| 17/04/26 | 07:00:03 | 17 Apr 2026 | | Transaction in Own Shares |
| 16/04/26 | 15:30:01 | 16 Apr 2026 | | Director/PDMR Shareholding |
| 16/04/26 | 07:00:02 | 16 Apr 2026 | | Transaction in Own Shares |
| 15/04/26 | 07:12:06 | 15 Apr 2026 | | GSK completes acquisition of 35Pharma Inc. |
| 15/04/26 | 07:00:04 | 15 Apr 2026 | | Transaction in Own Shares |
| 14/04/26 | 15:30:00 | 14 Apr 2026 | | Director/PDMR Shareholding |
| 14/04/26 | 07:00:02 | 14 Apr 2026 | | Transaction in Own Shares |
| 13/04/26 | 15:30:00 | 13 Apr 2026 | | Director/PDMR Shareholding |
| 13/04/26 | 07:00:05 | 13 Apr 2026 | | Transaction in Own Shares |
| 13/04/26 | 07:00:04 | 13 Apr 2026 | | GSK presents positive data for BEHOLD 1 B7 H4 ADC |
| 10/04/26 | 15:30:00 | 10 Apr 2026 | | Director/PDMR Shareholding |
| 10/04/26 | 07:00:04 | 10 Apr 2026 | | Transaction in Own Shares |
